Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
Preferred Stock
Common Stock [Member
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2018 2,774,394 810,856          
Beginning balance, value at Dec. 31, 2018 $ 2,774 $ 811 $ 168,170,244 $ (153,233,595) $ 253,734 $ (5,281,180) $ 9,912,788
Issuance of common stock and warrants in registered direct offering, net of issuance costs, shares 86,667          
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value $ 87 2,698,963 2,699,050
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, shares 1,746,666          
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, value $ 1,747 13,420,203 13,421,950
Issuance of common stock in connection with purchase of in-process research and development, shares 624,995          
Issuance of common stock in connection with purchase of in-process research and development, value $ 625 3,030,601 3,031,226
Exercise of pre-funded warrants, shares 612,417          
Exercise of pre-funded warrants, value $ 612 5,597 6,209
Exercise of purchase warrants, shares 2,201,553          
Exercise of purchase warrants, value $ 2,202 (2,202)
Issuance of common stock to vendor, shares 7,836          
Issuance of common stock to vendor, value $ 7 (7)
Issuance of warrants in connection with reverse stock split, shares          
Issuance of warrants in connection with reverse stock split, value 63,536 63,536
Issuance of common stock to adjust for reverse split rounding, shares 1,442          
Issuance of common stock to adjust for reverse split rounding, value $ 1 (1)
Deemed dividend related to Series B Preferred Stock down round provision 5,284,379 5,284,379
Accretion of deemed dividend related to Series B Preferred Stock down round provision (5,284,379) (5,284,379)
Share-based expense 806,090 806,090
Common stock awards to vendors 47,427 47,427
Net loss (12,775,025) (12,775,025)
Ending balance, shares at Dec. 31, 2019 2,774,394 6,092,432          
Ending balance, value at Dec. 31, 2019 $ 2,774 $ 6,092 188,240,451 (166,008,620) 253,734 (5,281,180) 17,213,251
Issuance of common stock in December 2020 registered direct offering, net of issuance costs, shares 2,448,980          
Issuance of common stock in December 2020 registered direct offering, net of issuance costs, value $ 2,449 5,424,376 5,426,825
Exercise of purchase warrants, shares 229,598          
Exercise of purchase warrants, value $ 229 (229)
Issuance of common stock to vendor, shares 1,188          
Issuance of common stock to vendor, value $ 1 (1)
Share-based expense 468,914 468,914
Net loss (10,893,466) (10,893,466)
Ending balance, shares at Dec. 31, 2020 2,774,394 8,772,198          
Ending balance, value at Dec. 31, 2020 $ 2,774 $ 8,771 $ 194,133,511 $ (176,902,086) $ 253,734 $ (5,281,180) $ 12,215,524